Log In
Print
BCIQ
Print
Print this Print this
 

belatacept (Nulojix) (LEA29Y)

Also known as: BMS-224818

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionFusion protein of CTLA-4 (CD152) and Ig
Molecular Target CD80 (B7-1) ; CD86 (B7-2)
Mechanism of ActionBinds CD80 (B7-1)
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today